Court Ruling Paves Way Ackman To Have His Way With Allergan

Allergan, Inc. (NYSE:AGN) is much closer to being a very changed company after a judge ruled in favor of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) and Bill Ackman’s Pershing Square Capital Management.

“We now expect Allergan to more aggressively consider its alternatives including a possible friendly deal with another pharmaceutical company or an acquisition of its own,” Shibani Malhotra, an analyst at Sterne Agee & Leach Inc., was quoted as saying in a Bloomberg report.

Allergan likely available at the right price

Sources close to the situation have noted that Allergan, Inc. (NYSE:AGN) is likely available, at the right price.  In previously sealed court documents reported by ValueWalk the question of the true value of...